Protalix BioTherapeutics Inc. (PLX)
AMEX: Health Care
$6.22
0.03 | 0.48%
0.03 | 0.48%
Today's Range:
6.15 -
6.22
PLX Avg. Daily Volume:
846,700
05/30/12 - 10:19 AM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 6.19 |
| 52 Week High | 7.70 |
| 52 Week Low | 4.06 |
| Avg. Daily Vol. (Mil) | 0.89 |
| Beta (3 year) | 1.68 |
| Share Related Items | |
| Mkt Cap (Mil) | 568.76 |
| Shares Out (Mil) | 91.88 |
| Float (Mil) | 71.67 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.60 |
| Current Ratio | 2.80 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | 14.40 |
| Price/Sales | 71.22 |
| Price/Book | 0.00 |
| Price/Cash Flow | -16.90 |
| Per Share Data | |
| Earnings | 0.43 |
| Sales | 0.09 |
| Book Value | 0.00 |
| Cash Flow | -0.37 |
| Business Summary | |
|---|---|
| Protalix BioTherapeutics, Inc. operate as biopharmaceutical companies focused on the development and commercialization of recombinant therapeutic proteins based on the Company's proprietary ProCellExtm protein. | |
| General Information | |
| 2 Snunit Street
Science Park Carmiel, 20100 |
|
| www.protalix.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 235 | |
| CEO: Dr. David Aviezer,PhD | |
| Short Interest | |
| Current Month (Mil) | 5.18 |
| Previous Month (Mil) | 4.45 |
| Short Interest Ratio (Days) | 3.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -54.60 |
| Return on Investments | 578.00 |
| Profitability | |
| Gross Margin | 52.40 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,456.72 | 1,315.70 | 2,838.43 | 16.47 |
Oil *
104.05
|
|
DOWN
123.97 |
DOWN
16.72 |
DOWN
32.56 |
DOWN
0.84 |
10 Yr
1.65%
SPDR Gold
149.70
|
|
-0.99%
|
-1.25%
|
-1.13%
|
-4.85%
|
Data delayed 20 minutes |
Connect with TheStreet